Product Description: Perenostobart is a human immunoglobulin G4-kappa, anti-ENTPD1/CD39 monoclonal antibody. Perenostobart is an immunostimulant and antineoplastic[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
CAS Number: 2643331-31-9
Molecular Weight: N/A
Compound Purity: 97.00
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: NTPDase